by Kenjiro | Jun 22, 2022 | news
In April of 2022, a MIT feasibility grant was made available to further explore market opportunities for the implementation of tests for STI’s. Rapidemic has been awarded the €20 000 grant by the RVO and the province Zuid-Holland to continue their market research for...
by Kenjiro | Jun 18, 2022 | news
In June, Rapidemic participated in the 2022 edition of the Sustainable Healthcare Challenge in Jaarbeurs Rotterdam. The Sustainable Healthcare Challenge (SHC) forms a bridge between young entrepreneurs, professionals en healthcare insitutions. Through their events,...
by Kenjiro | Jun 16, 2022 | news
On June 16th, Rapidemic founder Violette Defourt, joined Philips CEO, Frans van Houten, for a lunch lecture at the Erasmus Medical Center, organized by Graduate Entrepreneur. The two had met a year earlier for the Philips Innovation Award. During the lecture, Frans...
by Kenjiro | May 15, 2022 | news
In May of 2022, Rapidemic’s research team has created its first functional proof-of-concept for their groundbreaking platform technology for decentralized nucleic acid detection. The molecular test comprises a DNA amplification reaction, coupled to an easy, universal...
by Kenjiro | May 2, 2022 | news
In May of 2022, the Rapidemic team moved into their new laboratory facilities, joining the BioPartner family on the Leiden Bioscience Park. The lab are located in the starters wing of the brand new circular BioPartner 5 building. We have purchased all the necessary...
